Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pegylated carfilzomib compounds

Pegylated carfilzomib compounds

US Patent 10517954 · Granted Dec 31, 2019

Estimated economic value: $319,046,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds as GLP-1R agonists2025
Compounds as GLP-IR agonists2025
Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)-1H-pyrazolo[3,42025
Bispecific antibodies with cleavable C-terminal charge-paired tags2025
Compounds useful for treating gastrointestinal tract disorders2025
Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)-1H-pyrazolo[3,4-2025
Compounds as GLP-1R agonists2024
Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway2024
Glycyrrhetinic acid derivatives for use in treating hyperkalemia2024
Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)-1H-pyrazolo[3,42023
Glycyrrhetinic acid derivatives for treating hyperkalemia2023
Solid forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidi2023